Application of Cognitive Bias Testing in Neuropsychiatric Disorders: A Mini-Review Based on Animal Studies.
affective state
animal research
application
cognitive bias test
interpretation bias
memory bias
Journal
Frontiers in behavioral neuroscience
ISSN: 1662-5153
Titre abrégé: Front Behav Neurosci
Pays: Switzerland
ID NLM: 101477952
Informations de publication
Date de publication:
2022
2022
Historique:
received:
20
04
2022
accepted:
13
06
2022
entrez:
18
7
2022
pubmed:
19
7
2022
medline:
19
7
2022
Statut:
epublish
Résumé
Cognitive biases can arise from cognitive processing under affective states and reflect the impact of emotion on cognition. In animal studies, the existing methods for detecting animal emotional state are still relatively limited, and cognitive bias test has gradually become an important supplement. In recent years, its effectiveness in animal research related to neuropsychiatric disorders has been widely verified. Some studies have found that cognitive bias test is more sensitive than traditional test methods such as forced swimming test and sucrose preference test in detecting emotional state. Therefore, it has great potential to become an important tool to measure the influence of neuropsychiatric disorder-associated emotions on cognitive processing. Moreover, it also can be used in early drug screening to effectively assess the potential effects or side effects of drugs on affective state prior to clinical trials. In this mini-review, we summarize the application of cognitive bias tests in animal models of neuropsychiatric disorders such as depression, anxiety, bipolar disorder, and pain. We also discussed its critical value in the identification of neuropsychiatric disorders and the validation of therapeutic approaches.
Identifiants
pubmed: 35846788
doi: 10.3389/fnbeh.2022.924319
pmc: PMC9283837
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
924319Informations de copyright
Copyright © 2022 Zhang, Wang, Lin, Wang and Luo.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Pain. 2021 Mar 1;162(3):956-966
pubmed: 33591111
PLoS One. 2015 Jul 29;10(7):e0132602
pubmed: 26222390
Lab Anim (NY). 2017 Mar 22;46(4):123-128
pubmed: 28328895
J Neurosci. 2007 May 30;27(22):5958-66
pubmed: 17537966
PLoS One. 2016 Mar 29;11(3):e0152592
pubmed: 27023442
Eur Neuropsychopharmacol. 2014 Jul;24(7):1103-11
pubmed: 24503278
Neurosci Biobehav Rev. 2019 May;100:335-343
pubmed: 30885811
Clin Psychol Rev. 2015 Dec;42:83-95
pubmed: 26379081
Neuropsychopharmacology. 2013 Oct;38(11):2188-96
pubmed: 23660704
Physiol Behav. 2021 Sep 1;238:113465
pubmed: 34029586
Elife. 2018 May 08;7:
pubmed: 29735014
Behav Brain Res. 2013 Nov 1;256:305-10
pubmed: 23993861
Physiol Behav. 2009 Sep 7;98(3):345-50
pubmed: 19560479
Nat Commun. 2019 Jan 17;10(1):301
pubmed: 30655534
Neuropharmacology. 2012 Jan;62(1):161-6
pubmed: 21722654
Curr Opin Psychol. 2019 Oct;29:266-273
pubmed: 31521030
Behav Brain Res. 2012 Jul 15;233(1):45-54
pubmed: 22562041
Am Psychol. 1981 Feb;36(2):129-48
pubmed: 7224324
Clin Psychol Rev. 2012 Dec;32(8):704-23
pubmed: 23059623
Behav Brain Res. 2019 Apr 19;362:279-287
pubmed: 30654122
Behav Res Ther. 1995 Mar;33(3):335-43
pubmed: 7726811
Neuropsychopharmacology. 2015 Aug;40(9):2165-74
pubmed: 25740288
Lancet. 2013 May 11;381(9878):1672-82
pubmed: 23663953
Mol Psychiatry. 2001 Jan;6(1):13-34
pubmed: 11244481
Biol Lett. 2016 Jun;12(6):
pubmed: 27277950
Neuropsychopharmacology. 2020 Dec;45(13):2278-2288
pubmed: 32842137
Sci Rep. 2018 Aug 17;8(1):12400
pubmed: 30120315
Psychopharmacology (Berl). 2015 Jun;232(12):2149-56
pubmed: 25537337
Psychol Bull. 2008 Nov;134(6):886-911
pubmed: 18954160
Psychopharmacology (Berl). 2017 Oct;234(20):3105-3116
pubmed: 28735366
Front Behav Neurosci. 2020 Feb 12;14:14
pubmed: 32116594
Behav Brain Res. 2017 Jun 1;327:133-143
pubmed: 28212943
Neuropsychopharmacology. 2019 Aug;44(9):1623-1630
pubmed: 30978725
Neurosci Biobehav Rev. 2021 Jul;126:544-559
pubmed: 33848512
Anim Cogn. 2019 Nov;22(6):959-972
pubmed: 31250144
PLoS One. 2017 Sep 20;12(9):e0185129
pubmed: 28931086
Nature. 2004 Jan 22;427(6972):312
pubmed: 14737158
Front Hum Neurosci. 2013 Jul 04;7:328
pubmed: 23847501
Br J Pharmacol. 2017 Oct;174(19):3200-3210
pubmed: 28782244
Drugs. 1998 Aug;56(2):251-6; discussion 257
pubmed: 9711449
Front Behav Neurosci. 2017 Mar 21;11:51
pubmed: 28377703
Behav Brain Res. 2019 Oct 17;372:112051
pubmed: 31276704
PLoS One. 2012;7(10):e48143
pubmed: 23118942
J Affect Disord. 2015 Feb 1;172:315-23
pubmed: 25451432
Science. 2000 Jun 9;288(5472):1769-72
pubmed: 10846154
Neuropsychopharmacology. 2013 Aug;38(9):1625-35
pubmed: 23503126
PLoS One. 2013 Dec 04;8(12):e80556
pubmed: 24324609
J Affect Disord. 2019 Feb 15;245:1106-1113
pubmed: 30699853
PLoS One. 2015 Jul 08;10(7):e0130718
pubmed: 26154309
Curr Opin Psychol. 2021 Oct;41:9-14
pubmed: 33571802
Brain Res. 2011 Feb 10;1373:124-30
pubmed: 21156165
Neuropsychopharmacology. 2010 Mar;35(4):1008-15
pubmed: 20043002
Philos Trans R Soc Lond B Biol Sci. 2018 Mar 19;373(1742):
pubmed: 29352034
Disabil Rehabil. 2000 Jan 10-20;22(1-2):15-22
pubmed: 10661754
Neuropsychiatr Dis Treat. 2010 Oct 05;6:657-65
pubmed: 20957126
Eur Neuropsychopharmacol. 2017 Dec;27(12):1268-1280
pubmed: 29100819
J Health Psychol. 2020 Sep;25(10-11):1567-1575
pubmed: 29600730
Can J Psychiatry. 1988 Oct;33(7):577-84
pubmed: 3058289
Nat Rev Drug Discov. 2005 Sep;4(9):775-90
pubmed: 16138108
Sci Rep. 2018 May 29;8(1):8193
pubmed: 29844396
Clin Psychol Rev. 2012 Jul;32(5):413-24
pubmed: 22681914
Pharmgenomics Pers Med. 2020 Apr 23;13:127-140
pubmed: 32425581
Psychopharmacology (Berl). 2015 Feb;232(3):651-60
pubmed: 25116482
PLoS One. 2014 Aug 19;9(8):e105431
pubmed: 25137069
Psychol Bull. 1988 Mar;103(2):147-62
pubmed: 3283811
Curr Med Res Opin. 2020 May;36(5):713-730
pubmed: 32050807
Physiol Behav. 2017 May 15;174:18-26
pubmed: 28257935
Psychopharmacology (Berl). 2016 Jan;233(2):225-33
pubmed: 26449721
Psychol Assess. 2018 Nov;30(11):1527-1540
pubmed: 29878818
Prog Neuropsychopharmacol Biol Psychiatry. 2016 Jan 4;64:293-310
pubmed: 25891248
Sci Rep. 2020 Jul 16;10(1):11839
pubmed: 32678247
Lancet. 2020 Dec 5;396(10265):1841-1856
pubmed: 33278937
Cogn Affect Behav Neurosci. 2012 Sep;12(3):527-42
pubmed: 22644760